ImageneBio, Inc. financial data

Symbol
IMA on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 10 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1309% % 26%
Debt-to-equity -83% % -669%
Return On Equity 236% % 862%
Return On Assets -32% % -7.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11,181,672 shares -77%
Common Stock, Shares, Outstanding 48,258,111 shares 0%
Entity Public Float $41,700,000 USD -19%
Common Stock, Value, Issued $48,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 4,870,906 shares 308%
Weighted Average Number of Shares Outstanding, Diluted 48,258,111 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $3,500,000 USD 195%
Research and Development Expense $28,525,000 USD -11%
General and Administrative Expense $20,726,000 USD 147%
Operating Income (Loss) $48,451,000 USD -31%
Nonoperating Income (Expense) $2,752,000 USD 518%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $45,699,000 USD -25%
Income Tax Expense (Benefit) $350,000 USD -2792%
Net Income (Loss) Attributable to Parent $45,349,000 USD -24%
Earnings Per Share, Basic -9.64 USD/shares 56%
Earnings Per Share, Diluted -9.64 USD/shares 56%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $94,532,000 USD 680%
Marketable Securities, Current $40,817,000 USD
Assets, Current $140,288,000 USD 1025%
Property, Plant and Equipment, Net $0 USD -100%
Operating Lease, Right-of-Use Asset $790,000 USD 44%
Other Assets, Noncurrent $4,878,000 USD 379%
Assets $152,976,000 USD 861%
Accounts Payable, Current $1,439,000 USD -73%
Employee-related Liabilities, Current $2,888,000 USD 210%
Liabilities, Current $11,234,000 USD -35%
Operating Lease, Liability, Noncurrent $713,000 USD 198%
Other Liabilities, Noncurrent $870,000 USD
Liabilities $19,837,000 USD 14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $87,000 USD
Retained Earnings (Accumulated Deficit) $230,053,000 USD -28%
Stockholders' Equity Attributable to Parent $133,139,000 USD
Liabilities and Equity $152,976,000 USD 861%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $10,562,000 USD 42%
Net Cash Provided by (Used in) Investing Activities $7,932,000 USD
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 48,258,111 shares 0%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $94,532,000 USD 680%
Deferred Tax Assets, Valuation Allowance $91,556,000 USD 165%
Deferred Tax Assets, Gross $91,776,000 USD 164%
Operating Lease, Liability $2,975,000 USD -60%
Depreciation $87,000 USD -60%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $45,291,000 USD -24%
Lessee, Operating Lease, Liability, to be Paid $3,135,000 USD -61%
Property, Plant and Equipment, Gross $0 USD -100%
Operating Lease, Liability, Current $2,262,000 USD 632%
Lessee, Operating Lease, Liability, to be Paid, Year Two $719,000 USD -77%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,416,000 USD -43%
Operating Lease, Weighted Average Discount Rate, Percent 0.0856 pure -19%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $160,000 USD -73%
Lessee, Operating Lease, Liability, to be Paid, Year Three $720,000 USD -77%
Deferred Tax Assets, Operating Loss Carryforwards $60,906,000 USD 132%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares
Unrecognized Tax Benefits $901,000 USD 188%
Additional Paid in Capital $363,094,000 USD 16725%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $220,000 USD 58%
Share-based Payment Arrangement, Expense $14,000,000 USD 995%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%